Current therapies for common warts (verruca vulgaris) often require months of treatment and focus on destruction, removal of callus, or stimulation of a local immune response. Topical use of ingenol mebutate gel, 0.05%, indicated for the treatment of actinic keratosis, induces necrosis and an inflammatory reaction. A recent case study series provided evidence for the efficacy of ingenol mebutate against anogenital warts.
Neal D. Bhatia, MD
JAAD March 2018 Volume 78, Issue 3, Pages 595-596